ATE548385T1 - Neuer tumormarkierer - Google Patents

Neuer tumormarkierer

Info

Publication number
ATE548385T1
ATE548385T1 AT06025220T AT06025220T ATE548385T1 AT E548385 T1 ATE548385 T1 AT E548385T1 AT 06025220 T AT06025220 T AT 06025220T AT 06025220 T AT06025220 T AT 06025220T AT E548385 T1 ATE548385 T1 AT E548385T1
Authority
AT
Austria
Prior art keywords
growth factor
factor receptor
epithelial growth
tumor marker
new tumor
Prior art date
Application number
AT06025220T
Other languages
English (en)
Inventor
Silke Lankiewicz
Original Assignee
Qiagen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen Gmbh filed Critical Qiagen Gmbh
Application granted granted Critical
Publication of ATE548385T1 publication Critical patent/ATE548385T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • G01N33/5758—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT06025220T 2006-12-06 2006-12-06 Neuer tumormarkierer ATE548385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06025220A EP1930345B1 (de) 2006-12-06 2006-12-06 Neuer Tumormarkierer

Publications (1)

Publication Number Publication Date
ATE548385T1 true ATE548385T1 (de) 2012-03-15

Family

ID=37944894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06025220T ATE548385T1 (de) 2006-12-06 2006-12-06 Neuer tumormarkierer

Country Status (3)

Country Link
US (2) US20080305480A1 (de)
EP (1) EP1930345B1 (de)
AT (1) ATE548385T1 (de)

Also Published As

Publication number Publication date
US20100216148A1 (en) 2010-08-26
US20080305480A1 (en) 2008-12-11
EP1930345B1 (de) 2012-03-07
EP1930345A1 (de) 2008-06-11
US8158361B2 (en) 2012-04-17

Similar Documents

Publication Publication Date Title
CY1123175T1 (el) Παραγωγα πιπεριδιν-4-υλ αζετιδινης ως αναστολεις jak1
ATE540029T1 (de) 2,4-substituierte chinazoline als lipidkinasehemmer
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
CL2008000020A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos.
GT201200189A (es) Antagonistas de pcsk9
CY1116633T1 (el) Χρηση αναστολεων πεπτιδιου του μονοπατιου μεταγωγης σηματος jnk οι οποιοι διαπερνουν τα κυτταρα για τη θεραπευτικη αγωγη διαφορων καρδιαγγειακων νοσων
WO2008088854A3 (en) Genetic markers for predicting responsiveness to combination therapy
MX2009002816A (es) Proteinas de fusion de albumina.
EA201300052A1 (ru) [1,8]нафтиридиновые производные
CY1111714T1 (el) Δεσμευτικες πρωτεϊνες αυξητικου παραγοντα ηπατοκυτταρων (hgf).
EP3660510A3 (de) Muteine von humanem lipocalin 2 (lcn2, hngal) mit affinität für ein bestimmtes zielmolekül
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
CU24269B1 (es) 3- pirimidin- 4-il- oxazolidin- 2- onas inhibidores de la idh mutante
PT2121731E (pt) Vacinas peptídicas para cancros que expressam antigénios associados a tumores
NO20081307L (no) RNA antagonist sammensetninger for hemming av APO-B100 ekspresjon
TN2009000255A1 (en) Quinazolines for pdk1 inhibition
PH12012502102A1 (en) Fused bicyclic kinase inhibitors
TN2012000473A1 (fr) Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs
MX2009013765A (es) Polipeptidos y polinucleotidos para artemina y ligandos relacionados, y metodos de uso de los mismos.
PH12020551712A1 (en) Tissue-specific methylation marker
EP2274437A4 (de) Zusammensetzungen und verfahren zur erkennung von egfr-mutationen bei krebs
PL2005185T3 (pl) Sposoby identyfikowania celów polipeptydowych
ATE471722T1 (de) Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
SG156625A1 (en) Method for measuring resistance or sensitivity to docetaxel
EA201071422A1 (ru) Способы лечения заболеваний, связанных с мейотическим кинезином